Truist raised the firm’s price target on Booz Allen (BAH) to $185 from $165 and keeps a Hold rating on the shares. Booz Allen reported upside Q2 results and increased FY25 guidance across the board with the lower end of the EBITDA outlook exceeding the prior consensus estimate, the analyst tells investors in a research note. The firm remains on the sidelines as it believes Booz Allen’s multiple appropriately reflects the company’s superior organic growth and position to capture increasing AI/cyber demand.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAH:
- Booz Allen price target raised to $200 from $183 at TD Cowen
- Booz Allen price target raised to $206 from $185 at Wells Fargo
- Morning Movers: Capri sinks after judge blocks planned takeover by Tapestry
- BAH Earnings: Booz Allen Hamilton Reports Strong Q2 Results, Raises Outlook
- Booz Allen jumps 12% to $186.90 after Q2 results beat, FY25 guidance raised